Explore › Finding
Finding null
After excluding ESRD patients, there was no significant difference in 30-day amputation between bypass-first and endovascular-first revascularization (4.1% vs 6.2%; P=0.1), suggesting the amputation benefit of bypass is driven by the ESRD subgroup.
ComparatorEndovascular-first infrageniculate revascularization (non-ESRD patients)
Effect summarynull

Connected entities

Interventions
Bypass-first infrageniculate revascularization
Conditions
Chronic Limb-Threatening Ischemia
Outcomes
30-day major amputation

Source

PMC8906190
Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease
Read on PMC → · View in graph →